Human Bocavirus in Febrile Children Consulting a GP Service in the Netherlands by Montenij, M. (Miriam) et al.
Human Bocavirus in Febrile Children Consulting a GP Service in the Netherlands 
 
Miriam Monteny*, MD, Hubert G.M. Niesters†, PhD, Henriëtte A. Moll‡, PhD, 
Marjolein Y. Berger*, PhD  
 
* Department of General Practice, Erasmus MC, Rotterdam, The Netherlands 
† Department of Virology, Erasmus MC, Rotterdam, The Netherlands 
‡ Department of Pediatrics, Erasmus MC-Sophia, Rotterdam, The Netherlands 
 
Correspondence: 
Marjolein Berger, general practitioner, MD 
Erasmus MC 
Department of General Practice 
Room Ff 332 
PO Box 2040, 3000 CA Rotterdam, The Netherlands 
Tel. +31 10 408 7631, fax. +31 10 408 9491 
Email: m.berger@erasmusmc.nl
 
 
Word count: 800 
 
 
 
Keywords 
 1
Parvoviridae Infections 
Human BOCA virus 
Child 
Fever 
Communicable diseases, Emerging 
Family Practice 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 2
Abstract 
Human bocavirus (HBoV) was detected in nasopharyngeal swabs of 1.6% (95% CI 
0.4% to 3.9%) of 257 febrile children presented to a GP center. Symptoms of respiratory 
tract infection, gastrointestinal symptoms and skin rash were reported. Our results 
suggest HBoV as a pathogen causing mild disease in non-hospitalized febrile children. 
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Text 
Human bocavirus (HBoV) is a recently discovered virus of the family Parvoviridae, 
genus Bocavirus, and appears to be a widespread causative agent of respiratory tract 
infections (RTI) in children. In selected groups of children with RTI, detection rates 
varied between 2.8% and 11.3% (1-9). However, the exact prevalence and pathogenic 
impact of this virus remain to be established.  
During a prospective cohort study evaluating the prognosis of fever at a general 
practice out-of-hours service (GP service) in Rotterdam, nasopharyngeal swabs were 
collected from febrile children and tested for respiratory viruses including HBoV. We 
report the incidence and clinical features of HBoV in these children. 
Between June 1st 2005 and January 16th 2006, all children aged 3 months to 6 years 
contacting the GP service with fever as reason for encounter, reported by parents and not 
further defined, were eligible for inclusion. Children were excluded in case the parents 
could not communicate in Dutch (n =77) and in case a child had already been included 
within the last two weeks (n =11). A research nurse visited the child at home within 24 
hours after inclusion. The child was physically examined and a nasopharyngeal swab and 
blood sample for CRP measurement was collected. The parents subsequently registered 
symptoms in a diary during 7 days. The Central Committee on Research Involving 
Human Subjects (CCMO), The Netherlands, approved this study. 
Nucleic acids were isolated on a MagnaPure isolation station (Roche Applied Science, 
Penzberg, Germany) and subsequently analyzed by real time assays. Detection of HBoV 
was performed using a primers set and a FAM labeled TaqMan probe directed against 
sequences of the NP1 gene. Sequences are available through the corresponding author. 
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Routinely was tested for influenza virus types A and B, parainfluenza virus types 1-4, 
RSV types A and B, adenovirus, coronavirus (OC43, 229E and NL63) and rhinovirus. 
Nasopharyngeal swabs were collected from 257 children (81% of 319 enrolled 
children). The overall virus detection rate was 52.9% (most frequently adenovirus (11%), 
RSV-A (10.5%), parainfluenza virus type 1 (8.5%) and rhinovirus (8%)). Five children 
were included twice, none of them was HBoV-positive. The PCR for HBoV was positive 
in four children (1.6%), all boys. The characteristics of these children are shown in the 
table.  
All 4 children reported rhinorrhea and cough. Patient 1 reported abdominal pain, 
diarrhea (more than twice daily, with mucus), dyspnea and a skin rash along with 
respiratory symptoms. All symptoms lasted for more than a week. At physical 
examination the children were not or slightly ill. Patient 1 had a skin rash and palpable 
cervical lymph nodes. Patient 4 had palpable lymph nodes and red tonsils.  
Patient 1 was prescribed antibiotics for otitis media and patient 4 for tonsillitis, as 
diagnosed by the GP on the clinical presentation, without bacteriological confirmation. 
During one-week follow-up none of the patients had any further consultations. 
Our finding that HBoV may cause RTI is in accordance with the literature (1-6). Our 
findings support those of others in suggesting a role for HBoV in systemic infection, 
causing gastrointestinal symptoms and skin rash (6,8).  
Our detection rate, in general practice, is lower than the reported rates in former 
studies of children with RTI (3-10%) (1-8). Co-infection of HBoV and other viruses was 
found among three children out of four (table). In other studies co-infection was found in 
17.6% to 55.6% (mainly adenovirus, RSV and HMPV) (1,2,5,7-9). The other detected 
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viruses could have caused the symptoms of patients 2-4. However, HBoV was the only 
detected virus in one child with respiratory symptoms, gastrointestinal symptoms and 
rash, and might therefore be the pathogen. Considering the high amount of HBoV in 
patient 3, symptoms are likely caused by HBoV as well in this case. 
The severity of disease in our study population was limited since all children 
presented with mild disease and no child was hospitalized. However, all children reported 
a prolonged course of fever, more than 7 days or recurrent within a week. This is in 
contrast with the mean duration of fever of 2.6 days in the study of Arnold et al, which 
was based in hospital setting (6). None of the HBoV-positive children was diagnosed 
with bronchiolitis, pneumonia or bronchitis, as in previous studies. None of the four 
children in our study was born pre-term, compared to 19-44% of HBoV-positive children 
in previous studies (5,6). Neither did they have a positive history for asthma or other 
underlying diseases, as did up to 50% of the children in previous studies (1,6).  
In conclusion, HBoV was detected in nasopharyngeal swabs of 1.6% of 257 children 
younger than 6 years, presented with fever in general practice. Our results suggest that 
HBoV might cause mild disease with respiratory and gastrointestinal symptoms and skin 
rash. Further research to clarify the prevalence and pathogenicity of this new virus in the 
general population should not be restricted to susceptible or hospitalized patients alone. 
 
This study was supported by the Dutch Organization for Health Research and 
Development (ZonMw), Program Common Diseases.  
 
 
 6
Acknowledgments 
We thank Dr Ann Vossen of the Department of Virology, Erasmus MC for the analysis of 
the swabs (present address Department of Virology, University Medical Center Leiden). 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 7
First author’s biographical sketch 
Miriam Monteny is a PhD-student at the Department of General Practice of the Erasmus 
MC Rotterdam. She is a medical doctor and has a degree in Biomedical Sciences. Her 
primary research interests include infectious diseases in children in general practice and 
emergency medicine. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 8
References 
1. Allander T, Tammi MT, Eriksson M, Bjerkner A, Tiveljung-Lindell A, Andersson B.  
Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc 
Natl Acad Sci U S A. 2005;102(36):12891-6. 
2. Sloots TP, McErlean P, Speicher DJ, Arden KE, Nissen MD, Mackay IM. Evidence of 
human coronavirus HKU1 and human bocavirus in Australian children. J Clin Virol. 
2006;35(1):99-102. 
3. Ma X, Endo R, Ishiguro N, Ebihara T, Ishiko H, Ariga T et al. Detection of human 
bocavirus in Japanese children with lower respiratory tract infections. J Clin Microbiol. 
2006;44(3):1132-4. 
4. Bastien N, Brandt K, Dust K, Ward D, Li Y. Human Bocavirus infection, Canada. 
Emerg Infect Dis. 2006;12(5):848-50. 
5. Foulongne V, Rodiere M, Segondy M. Human Bocavirus in children. Emerg Infect 
Dis. 2006;12(5):862-3. 
6. Arnold JC, Singh KK, Spector SA, Sawyer MH. Human bocavirus: prevalence and 
clinical spectrum at a children's hospital. Clin Infect Dis. 2006;43(3):283-8. 
7. Weissbrich B, Neske F, Schubert J, Tollmann F, Blath K, Blessing K et al. Frequent 
detection of bocavirus DNA in German children with respiratory tract infections. BMC 
Infect Dis. 2006 Jul 11;6:109. 
8. Chung JY, Han TH, Kim CK, Kim SW. Bocavirus infection in hospitalized children, 
South Korea. Emerg Infect Dis. 2006 Aug;12(8):1254-6.  
9. Choi EH, Lee HJ, Kim SJ, Eun BW, Kim NH, Lee JA et al. The association of  
 
newly identified respiratory viruses with lower respiratory tract infections in Korean  
 
 9
children, 2000-2005. Clin Infect Dis. 2006 Sep 1;43(5):585-92.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 
 
 10
Patient Age 
(yr) 
Month 
collected 
Symptoms Body 
temperature 
(°C) 
CRP 
(mg/L) 
Positive PCR  
(log copies/mL) 
1 2.3 November 
2005 
Earache 
Rhinorrhea 
Cough 
Sore throat 
Abdominal 
pain 
Diarrhea 
Skin rash 
Dyspnea 
Increased 
breathing rate
36.2 9 Bocavirus 
(4.20) 
2 1.9 November 
2005 
Rhinorrhea 
Cough 
Sore throat 
Vomiting 
Increased 
breathing rate
38.8 26 Rhinovirus 
(7.57) 
RSV B 
(5.51) 
Bocavirus 
(2.88) 
3 1.3 December 
2005 
Earache 
Rhinorrhea 
Cough 
Headache 
Vomiting 
Skin rash 
Increased 
breathing rate
38.6 26 Bocavirus 
(6.72) 
Para-
influenzavirus 4 
(4.11) 
Adenovirus 
(2.00) 
4 1.0 January 
2006 
Earache 
Rhinorrhea 
Cough 
Sore throat 
Abdominal 
pain 
Diarrhea 
Vomiting 
37.7 88 Adenovirus 
(6.90) 
Bocavirus 
(2.88) 
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